Table 1 Characteristics of baseline/follow-up pairs and the respective patients, who underwent 68Ga-DOTATOC-PET/MRI at baseline and follow-up and who were analyzed to assess treatment-related changes
|  | Baseline/ follow-up pairs (N = 29) | Patients (N = 18) |
|---|---|---|
Age (years) | ||
 Median (range) | 58.6 (18–82) | 58.0 (18–82) |
Sex | N | N |
 Male | 21 | 12 |
 Female | 8 | 6 |
Primary | N | Â |
 Pancreas | 17 | 11 |
 Small intestine | 10 | 5 |
 Lungs | 1 | 1 |
 Kidney | 1 | 1 |
Grading | N | Â |
 1 | 9 | 5 |
 2 | 14 | 10 |
 3 | 6 | 3 |
Treatment response | ||
 Treatment response | 23 |  |
 No response | 6 |  |
Systemic treatment | ||
 SSA | 13 |  |
 PRRT | 10 |  |
 Chemotherapy | 2 |  |
 Sunitinib | 2 |  |
 None | 2 |  |